US$ 23.94
bpc-157 prime capsules product information Rapid BPC 157 | 𝟏𝟓𝟕 𝐂𝐚́𝐩𝐬𝐮𝐥𝐚𝐬
Description
This screen identified the hexanoic N-terminal substituent as the most active compound

Retatrutide : This triple agonist (GLP-1 + GIP + glucagon) produced 28.7% weight loss in Phase 3 but introduced a new safety signal: dysesthesia (abnormal skin sensations) in 4.4 to 20.9% of participants at the 12 mg dose depending on trial population

In terms of side effects and tolerability, the advantage goes to CagriSema
No big RCTs evaluate BPC-157 for fertility outcomes, such as conception, live birth, or enhanced ovarian reserve
